Corebridge Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,044
Closed -$150K 1894
2025
Q1
$150K Sell
10,044
-823
-8% -$12.7K ﹤0.01% 2236
2024
Q4
$162K Sell
10,867
-1,165
-10% -$19K ﹤0.01% 2293
2024
Q3
$230K Sell
12,032
-762
-6% -$15.8K ﹤0.01% 2151
2024
Q2
$265K Buy
+12,794
New +$254K ﹤0.01% 2029

Other funds holding OGN

Corebridge Financial's OGN Position: Q2 2025 in Review

Corebridge Financial sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 10,044 shares — an estimated $150K sold.

Corebridge Financial first reported a position in OGN in Q2 2024 and held it in 4 quarters. The position peaked at $265K in Q2 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Corebridge Financial reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 10,044 Organon & Co shares in Q2 2025, an estimated $150K.
  • Corebridge Financial first reported a position in Organon & Co in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Organon & Co position peaked at $265K in Q2 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.